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Background
As the protein quality control centre of the cell molecu-
lar chaperones tightly regulate amyloid proteins and
seem to alleviate their cytotoxicity. However, the precise
mechanism of this interplay and how its modification
leads to disease remain elusive.
Particularly oligomeric species of amyloid proteins
have emerged as the most important mediators of neuro-
toxicity in neurodegenerative diseases. However, these
oligomers are exceedingly hard to characterize as they
are transient, heterogeneous and rare relative to the
monomeric and fibrillar states. We have developed single
molecule FRET techniques for the time-resolved detec-
tion and characterisation of oligomeric species [1-3].
Here, we characterise the oligomers evolving during
the aggregation of a tau variant carrying the Δ280K
mutation associated with some forms of frontotemporal
dementia. Further, we study the interaction of these oli-
gomers with the intracellular chaperone Hsp70 which
has previously been identified as a key regulator of tau
turnover.
Materials and methods
We perform single-molecule FRET measurements for
the detection of dual labelled tau oligomers. On a confo-
cal setup two lasers of different wavelengths are over-
lapped to excite a sub-femtolitre confocal volume. The
heparin induced tau oligomers at picomolar concentra-
tions are flowed through the confocal volume using a
microfluidic device and coincident fluorescent bursts of
donor and receptor fluorophores are readily detected.
Analysing the frequency and intensity of these bursts
allows us to determine the amount and stoichiometries
of the oligomers.
Results
Δ280K tau oligomerisation is rapid with a maximum
number of oligomers observed approximately 45 min-
utes after heparin induction.
In the presence of Hsp70 fewer oligomers are detected
and fibrillisation is inhibited in a dose dependent man-
ner. In more detail, more medium sized oligomers
(6-20mers) and fewer small sized oligomers (2-5mers)
are found in presence of the chaperone.
These effects were observed in absence of nucleotides
and were found to be abrogated in the presence of ADP
or ATP.
Conclusions
Hsp70 interacts with Δ280K tau oligomers to slow down
the rapid fibrillisation of the amyloid protein. This inhi-
bitory effect seems to be due to preferential stabilization
of medium sized oligomers and occurs in the absence of
nucleotides.
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